Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Z7OB
|
|||
| Former ID |
DNC006025
|
|||
| Drug Name |
(E)-N-(3,5-dimethoxyphenethyl)undec-2-enamide
|
|||
| Synonyms |
CHEMBL373056; (E)-N-(3,5-dimethoxyphenethyl)undec-2-enamide
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H33NO3
|
|||
| Canonical SMILES |
CCCCCCCCC=CC(=O)NCCC1=CC(=CC(=C1)OC)OC
|
|||
| InChI |
1S/C21H33NO3/c1-4-5-6-7-8-9-10-11-12-21(23)22-14-13-18-15-19(24-2)17-20(16-18)25-3/h11-12,15-17H,4-10,13-14H2,1-3H3,(H,22,23)/b12-11+
|
|||
| InChIKey |
RWXZZBVYJHEKRB-VAWYXSNFSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cannabinoid receptor 1 (CB1) | Target Info | Inhibitor | [1] |
| Cannabinoid receptor 2 (CB2) | Target Info | Inhibitor | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Rap1 signaling pathway | ||||
| Retrograde endocannabinoid signaling | ||||
| Panther Pathway | Endogenous cannabinoid signaling | |||
| Pathway Interaction Database | N-cadherin signaling events | |||
| Reactome | Class A/1 (Rhodopsin-like receptors) | |||
| G alpha (i) signalling events | ||||
| WikiPathways | GPCRs, Class A Rhodopsin-like | |||
| Small Ligand GPCRs | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| BDNF signaling pathway | ||||
| GPCRs, Other | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | New metabolically stable fatty acid amide ligands of cannabinoid receptors: Synthesis and receptor affinity studies. Bioorg Med Chem Lett. 2006 Jan 1;16(1):138-41. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.